NovaBay Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Emeryville, California and currently employs 14 full-time employees. The company went IPO on 2007-10-26. NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The firm manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
Wall Street analistlerine göre, 2 analist NovaBay Pharmaceuticals Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 1 güçlü al, 3 al, 1 tut, 0 sat ve 1 güçlü sat içermektedir